Yield10 Bioscience Inc
NASDAQ:YTEN
Operating Margin
Yield10 Bioscience Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Operating Margin Comparison
Yield10 Bioscience Inc Competitors
Country | US |
Market Cap | 4.2m USD |
Operating Margin |
-24 028%
|
Country | US |
Market Cap | 292.2B USD |
Operating Margin |
30%
|
Country | US |
Market Cap | 142B USD |
Operating Margin |
29%
|
Country | US |
Market Cap | 102B USD |
Operating Margin |
39%
|
Country | US |
Market Cap | 98.2B USD |
Operating Margin |
32%
|
Country | AU |
Market Cap | 130.2B AUD |
Operating Margin |
26%
|
Country | US |
Market Cap | 82.9B USD |
Operating Margin |
30%
|
Country | US |
Market Cap | 43.1B USD |
Operating Margin |
-33%
|
Country | US |
Market Cap | 39.4B USD |
Operating Margin |
-62%
|
Country | US |
Market Cap | 27.7B USD |
Operating Margin |
21%
|
Country | IE |
Market Cap | 26.6B USD |
Operating Margin |
16%
|
Profitability Report
View the profitability report to see the full profitability analysis for Yield10 Bioscience Inc.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Yield10 Bioscience Inc's most recent financial statements, the company has Operating Margin of -24 028.3%.